Literature DB >> 28877633

Targeting the PSGL-1 pathway for immune modulation.

Roberto Tinoco1, Linda M Bradley1.   

Abstract

Entities:  

Keywords:  LCMV; PSGL-1; checkpoint; coinhibitory; costimulatory; melanoma

Mesh:

Substances:

Year:  2017        PMID: 28877633      PMCID: PMC5618955          DOI: 10.2217/imt-2017-0078

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  20 in total

Review 1.  Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation.

Authors:  Klaus Ley; Geoffrey S Kansas
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantation.

Authors:  Sei-ichiro Tsuchihashi; Constantino Fondevila; Gray D Shaw; Meike Lorenz; Kimberly Marquette; Susan Benard; Xiu-Da Shen; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

3.  Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice.

Authors:  J William Phillips; Kurt G Barringhaus; John M Sanders; Sean E Hesselbacher; Ann C Czarnik; David Manka; Dietmar Vestweber; Klaus Ley; Ian J Sarembock
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

4.  Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs.

Authors:  Krystle M Veerman; Michael J Williams; Kenji Uchimura; Mark S Singer; Jasmeen S Merzaban; Silvia Naus; Douglas A Carlow; Philip Owen; Jesús Rivera-Nieves; Steven D Rosen; Hermann J Ziltener
Journal:  Nat Immunol       Date:  2007-04-01       Impact factor: 25.606

5.  PSGL-1 regulates the migration and proliferation of CD8(+) T cells under homeostatic conditions.

Authors:  Krystle M Veerman; Douglas A Carlow; Iryna Shanina; John J Priatel; Marc S Horwitz; Hermann J Ziltener
Journal:  J Immunol       Date:  2012-01-16       Impact factor: 5.422

Review 6.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 7.  Targeting T Cell Co-receptors for Cancer Therapy.

Authors:  Margaret K Callahan; Michael A Postow; Jedd D Wolchok
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

8.  P-selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism.

Authors:  Tao Xu; Lei Zhang; Zhen H Geng; Hai-Bo Wang; Jin-Tao Wang; Ming Chen; Jian-Guo Geng
Journal:  Cell Adh Migr       Date:  2007-07-05       Impact factor: 3.405

9.  Isolated P-selectin glycoprotein ligand-1 dynamic adhesion to P- and E-selectin.

Authors:  D J Goetz; D M Greif; H Ding; R T Camphausen; S Howes; K M Comess; K R Snapp; G S Kansas; F W Luscinskas
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

10.  PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Barraza; Dennis C Otero; Jonathan Magaña; Marcus W Bosenberg; Susan L Swain; Linda M Bradley
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more
  1 in total

Review 1.  The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.

Authors:  Benjamin A H Smith; Carolyn R Bertozzi
Journal:  Nat Rev Drug Discov       Date:  2021-01-18       Impact factor: 84.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.